Possible English title: Juul Labs explores funding options amid lawsuits and FDA regulations.
Electronic cigarette manufacturer Juul Labs is reportedly preparing to raise funds amidst a series of consumer lawsuits and regulatory uncertainty. The US Food and Drug Administration (FDA) is attempting to force the company to withdraw from the American market. Juul is exploring its options, which may include filing for bankruptcy and awaiting further action from the FDA and the outcome of consumer lawsuits. It faces potential compensation claims amounting to hundreds of millions of dollars.
Bloomberg News reports, citing unnamed sources, that the company has hired Centerview Partners as its banker to assist with financing, and has also enlisted Kirkland & Ellis and Alvarez & Marsal to provide litigation and restructuring advice.
A spokesperson for Juul stated in an email to Axios that they are currently in the early stages of exploring various options, including potential financing choices, to protect their business as they continue to operate in the market and pursue an appeal with the FDA.
We have confidence in our science and evidence, and believe that we can demonstrate that our product does meet the legal standards for 'fit for protecting public health'.
Overall, as one of the more popular brands of electronic cigarettes, Juul's fate is closely watched as it may have an impact on the broader $23.6 billion electronic cigarette market.
What's next: It's a waiting game as the FDA conducts its review and the courts consider Juul's appeal of the ban.
In order to remain in the market, companies must demonstrate that their electronic cigarettes are beneficial to public health. In practice, this means proving that adult smokers who use electronic cigarettes may quit or reduce their smoking, while teenagers are unlikely to become addicted to electronic cigarettes.
This article is compiled from third-party information and is intended for educational and informational purposes only. The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for removal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
